VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED
Clinical trials for VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED explained in plain language.
Never miss a new study
Get alerted when new VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED trials appear
Sign up with your email to follow new studies for VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control many different types of rare, advanced cancers that have limited treatment options. It enrolled over 800 adults whose cancer progressed after standard therapy. The g…
Matched conditions: VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 05:06 UTC
-
Major trial aims to boost survival for advanced gynecologic cancers
Disease control OngoingThis large, late-stage trial is testing whether adding a new drug called triapine to the standard treatment of radiation and chemotherapy (cisplatin) works better for women with newly diagnosed, advanced cervical or vaginal cancer. The goal is to see if the three-drug combination…
Matched conditions: VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New drug combo tested against rare, Tough-to-Treat cancers
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs, atezolizumab and bevacizumab, can help control several rare types of advanced solid tumors. The trial is for adults whose cancer has spread or returned after other treatments. The goal is to see if this drug …
Matched conditions: VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC